HomeVRAX • NASDAQ
add
Virax Biolabs Group Ltd
Previous close
$0.70
Day range
$0.67 - $0.73
Year range
$0.61 - $5.45
Market cap
1.63M USD
Avg Volume
21.42K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 38.25K | 1,228.12% |
Operating expense | 1.36M | 88.57% |
Net income | -1.45M | -101.55% |
Net profit margin | -3.80K | 84.82% |
Earnings per share | — | — |
EBITDA | -1.35M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 5.21M | 13.90% |
Total assets | 7.03M | 32.58% |
Total liabilities | 919.05K | -19.56% |
Total equity | 6.11M | — |
Shares outstanding | 1.81M | — |
Price to book | 0.20 | — |
Return on assets | -48.15% | — |
Return on capital | -53.80% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -1.45M | -101.55% |
Cash from operations | -1.73M | -50.56% |
Cash from investing | -354.09K | — |
Cash from financing | -39.41K | -101.15% |
Net change in cash | -2.12M | -193.32% |
Free cash flow | -1.15M | -250.16% |
About
Founded
2013
Website
Employees
11